RxDoctor Payments Data

Hannah Pollard

Nurse Practitioner · Ranburne, ALNPI 1952854572

Payments from drug & device makers

$3,335in general payments, 2019–2025

Across 230 payments — averaging $14.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$364
  • Lilly USA, LLC$267
  • Amgen$230
  • Otsuka America Pharmaceutical, Inc.$155
  • Novartis$146
  • plus $757 from 21 others

What the payments were for

  • Food & beverage$3,335100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,335 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$22,287
OzempicSemaglutide16$18,561
MyrbetriqMirabegron22$10,186
LinzessLinaclotide13$10,173
EliquisApixaban16$9,198
XareltoRivaroxaban12$7,105
Rivastigmine12$1,601
Albuterol Sulfate HfaAlbuterol Sulfate38$1,012
Tretinoin11$969
Fluoxetine Hcl30$861
Armour ThyroidThyroid,pork12$711
Duloxetine Hcl35$533
Memantine Hcl12$517
Levothyroxine Sodium82$458
Escitalopram Oxalate44$437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$267$22,28721 claims
Novo NordiskOzempic$364$18,56116 claims
AbbVieLinzess, Armour Thyroid$1,417$10,88425 claims
Astellas Pharma US IncMyrbetriq$48$10,18622 claims
PfizerEliquis$126$9,19816 claims
Johnson & JohnsonXarelto$79$7,10512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.

Other nurse practitioner in Ranburne

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →